Thursday, March 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

U.S. Army Seeks Continuation of Forum on Microbial Threats

by Global Biodefense Staff
April 14, 2017
The Up-Hill Battle of Antibiotic Resistance in the World of Infection Prevention

Hospital-Associated Methicillin-resistant Staphylococcus aureus (MRSA). The bacteria shown is strain MRSA252, a leading cause of hospital-associated infections in the U.S. and U.K. Credit: NIAID

The US Army Medical Research and Materiel Command (USAMRMC) is seeking participation in a committee composed of the nation’s top scientists, engineers and other experts, in order to discuss key stakeholder issues surrounding antimicrobial resistance.

A contract was awarded to the National Academies of Sciences on in 2014 for participation in the Forum on Microbial Threats. The Forum is uniquely positioned to stimulate original thinking about new as well as long-standing problems in areas related to Microbial Resistance due to the unofficial nature of its deliberations coupled with the neutrality of the National Academies.

The period of performance of the current contract ends in September 2017. This Request for Information is to gauge interest in the upcoming requirement for USAMRMC participation in the Forum of Microbial Threats and to determine if there are any other Forums or Committees available to provide these services.

The purpose of the Forum is to:

  • Promote a regular and ongoing exchange of information and ideas about critical issues among stakeholders
  • Clarify policy and research issues and identify options that require additional emphasis and research, and encourage leading scientists, public health professionals, medical care providers, private industry, and others to further explore these areas
  • Inform public and private sector decision- and policymakers about the scientific basis and public health needs and understanding related to infectious diseases
  • Create priority and collaborative initiatives that require in-depth analysis of existing data and research, particularly in instances where new strategies are necessary to advance progress on the emergence, detection, and response to infectious diseases.

Information received will be used to determine industry capabilities and determine whether a contract can be executed on a sole source basis.

Further details are available via Solicitation Number: W81XWH-17-RFI-02.

Editor also recommends:

  • Rapid Medical Countermeasure Response to Infectious Diseases: Enabling Sustainable Capabilities Through Ongoing Public- and Private-Sector Partnerships
  • The Ebola Epidemic in West Africa: Proceedings of a Workshop
  • Big Data and Analytics for Infectious Disease Research, Operations, and Policy: Proceedings of a Workshop
  • Global Health Impacts of Vector-Borne Diseases: Workshop Summary
Tags: AntimicrobialsRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC